FDA-cleared profile

CT VScore+

Canon Medical Informatics, Inc. · CT/CTA · FDA-cleared (510(k))

Authorized purpose: CT VScore+ evaluates calcified coronary lesions on ECG-gated, non-contrast cardiac CT in patients aged 30 years or older, automatically generating coronary calcium scores and highlighted calcium segmentation for qualified clinical review.

Clinical role
Coronary calcium scoring and supplementary calcium segmentation for clinical risk-context reporting; the segmentation map and 3D view are not stand-alone diagnostic outputs.
Images and patients
CT/CTA · Heart/Cardiovascular
Key limitation
Keep in mind: The automated output combines LM+LAD; separate LM and LAD results require manual segmentation. The segmentation map is informational, the 3D Calcium View is supplementary, and the FDA validation observed nonzero assignments in 9 of 50 confirmed zero-calcium cases, so low scores require physician review.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: CT VScore+ evaluates calcified coronary lesions on ECG-gated, non-contrast cardiac CT in patients aged 30 years or older, automatically generating coronary calcium scores and highlighted calcium segmentation for qualified clinical review.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Heart/Cardiovascular Input: ECG-gated, non-contrast cardiac CT DICOM images for patients aged 30 years or older.
  • Who uses it?Intended users: Qualified healthcare professionals reviewing cardiac CT; the FDA summary describes user editing of automated segmentation but does not establish a broader credentialing program.
  • What does the software produce?Output: Agatston and volume scores for combined LM+LAD, RCA, and LCX; highlighted calcium segmentation; optional MESA and Hoff-Kondos reference context; DICOM image and DICOM Structured Report export.
  • What is its most important limitation?Key limitation: The automated output combines LM+LAD; separate LM and LAD results require manual segmentation. The segmentation map is informational, the 3D Calcium View is supplementary, and the FDA validation observed nonzero assignments in 9 of 50 confirmed zero-calcium cases, so low scores require physician review.

Clinical takeaway. Clinical role: CT VScore+ evaluates calcified coronary lesions on ECG-gated, non-contrast cardiac CT in patients aged 30 years or older, automatically generating coronary calcium scores and highlighted calcium segmentation for qualified clinical review.

Evidence takeaway. Evidence from the reviewed source record: K252217 FDA evidence is a regulatory agreement and segmentation-validation package for CT VScore+; no independent clinical outcomes or comparative paper were promoted in this timeboxed review.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
CT VScore+ evaluates calcified coronary lesions on ECG-gated, non-contrast cardiac CT in patients aged 30 years or older, automatically generating coronary calcium scores and highlighted calcium segmentation for qualified clinical review.
  • Exact FDA submission
  • Checked 2026-09-07
Workflow role
Coronary calcium scoring and supplementary calcium segmentation for clinical risk-context reporting; the segmentation map and 3D view are not stand-alone diagnostic outputs.
  • Exact FDA submission
  • Checked 2026-09-07
Required input
ECG-gated, non-contrast cardiac CT DICOM images for patients aged 30 years or older.
  • Exact FDA submission
  • Checked 2026-09-07
Output and clinician action
Agatston and volume scores for combined LM+LAD, RCA, and LCX; highlighted calcium segmentation; optional MESA and Hoff-Kondos reference context; DICOM image and DICOM Structured Report export.
  • Exact FDA submission
  • Checked 2026-09-07
Care setting
Cardiac CT, cardiology, or radiology workflow on the Vitrea platform.
  • Exact FDA submission
  • Checked 2026-09-07
Intended users
Qualified healthcare professionals reviewing cardiac CT; the FDA summary describes user editing of automated segmentation but does not establish a broader credentialing program.
  • Exact FDA submission
  • Checked 2026-09-07
Limitations
The automated output combines LM+LAD; separate LM and LAD results require manual segmentation. The segmentation map is informational, the 3D Calcium View is supplementary, and the FDA validation observed nonzero assignments in 9 of 50 confirmed zero-calcium cases, so low scores require physician review.
  • Exact FDA submission
  • Checked 2026-09-07
Evidence summary
K252217 FDA evidence is a regulatory agreement and segmentation-validation package for CT VScore+; no independent clinical outcomes or comparative paper were promoted in this timeboxed review.
  • Exact FDA submission
  • Checked 2026-09-07

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
K252217 FDA evidence is a regulatory agreement and segmentation-validation package for CT VScore+; no independent clinical outcomes or comparative paper were promoted in this timeboxed review.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Total Agatston Score ICC

0.997 ICC

  • EndpointAgreement with reference total Agatston score
  • Population236 independent pivotal validation cases from diverse U.S. sites and scanner vendors
  • Tested versionCT VScore+ as described in K252217

CAC-DRS four-class kappa

0.959 Cohen kappa

  • EndpointAgreement for four-class CAC-DRS risk classification
  • Population236 independent pivotal validation cases
  • Tested versionCT VScore+ as described in K252217

Zero-calcium cases assigned nonzero

18 percent

  • EndpointConfirmed zero-calcium cases assigned a nonzero score
  • PopulationConfirmed zero-calcium cases in the pivotal validation set
  • Tested versionCT VScore+ as described in K252217

K252217 development and pivotal validation for CT VScore+

  • DesignRetrospective regulatory performance validation with separate development and pivotal datasets; three U.S. board-certified physicians reviewed validation cases.
  • PopulationPatients aged 30 years or older with eligible ECG-gated non-contrast cardiac CT
  • Scopeexact submission
  • Tested versionCT VScore+ configuration described in K252217
  • Samplen=236
  • IndependenceSponsor or vendor study

K252217

Manufacturer-submitted FDA evidence; it is not independent clinical-outcome validation.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The wave22 exact-submission recall query returned no native recall record for K252217. This does not establish absence of family, later-version, or adverse-event information.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-07
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: ECG-gated, non-contrast cardiac CT DICOM images for patients aged 30 years or older.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-07 · FDA 510(k) K252217: CT VScore+

  2. Routing

    Source context, not route validation: The software runs on Vitrea, processes DICOM, and can export results to DICOM-capable image management, archival, or reporting systems and as DICOM SR; site-specific interface and routing compatibility require testing.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-07 · FDA 510(k) K252217: CT VScore+

  3. AI processing

    Source context, not route validation: Vitrea platform deployment is established by the FDA summary; public material reviewed does not establish the exact site hosting topology, infrastructure prerequisites, retention, availability, or service boundary for K252217.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-07 · FDA 510(k) K252217: CT VScore+

  4. Returned objects

    Source context, not route validation: Agatston and volume scores for combined LM+LAD, RCA, and LCX; highlighted calcium segmentation; optional MESA and Hoff-Kondos reference context; DICOM image and DICOM Structured Report export.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-07 · FDA 510(k) K252217: CT VScore+

  5. Viewer/worklist/report

    Unresolved route: Agatston and volume scores for combined LM+LAD, RCA, and LCX; highlighted calcium segmentation; optional MESA and Hoff-Kondos reference context; DICOM image and DICOM Structured Report export.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-07 · FDA 510(k) K252217: CT VScore+

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Vitrea platform deployment is established by the FDA summary; public material reviewed does not establish the exact site hosting topology, infrastructure prerequisites, retention, availability, or service boundary for K252217.
  • Exact FDA submission
  • Checked 2026-09-07
Integration
The software runs on Vitrea, processes DICOM, and can export results to DICOM-capable image management, archival, or reporting systems and as DICOM SR; site-specific interface and routing compatibility require testing.
  • Exact FDA submission
  • Checked 2026-09-07
Training
Use requires qualified clinical review of automated scores and segmentation; local onboarding should cover the exact CT protocol, manual LM/LAD assignment, low-score limitations, export behavior, and escalation.
  • Exact FDA submission
  • Checked 2026-09-07
Monitoring
Monitor protocol acceptance, score and segmentation edits, low-score false-positive behavior, DICOM/SR delivery, failed or repeated analyses, reader overrides, downtime, updates, complaints, and recalls by exact K252217 build.
  • Exact FDA submission
  • Checked 2026-09-07

Buyer acceptance guidance derived from the exact intended inputs, outputs, and validation limitations; it is not a claimed vendor monitoring service.

Vitrea platform dependency

The exact submission runs on the Vitrea platform and processes eligible ECG-gated non-contrast cardiac CT DICOM images.

exact submission · checked 2026-09-07

DICOM and structured reporting

Results can be exported to DICOM-capable image management, archive, or reporting systems and saved as DICOM SR; validate local routing, identifiers, and report ingestion.

exact submission · checked 2026-09-07

Current Canon workflow

Canon describes CT VScore+ as automating routine coronary calcium scoring for in-house cardiac CT operations, with structured data export through the Export+ add-on.

product family · checked 2026-09-07

Current family page context; it does not establish that the K252217 release includes every current add-on or workflow feature.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K252217
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-11-28
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-07Last searched
24Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The stored PubMed and ClinicalTrials.gov candidate arrays were screened and were empty. No paper or trial was promoted; empty stored arrays do not establish that no external literature or trials exist. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, fda device recall, literature index, trial registry, stored candidate metadata, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-07 - Exact FDA submission

    No public list price for the exact K252217 configuration was established in the reviewed official sources; obtain a quote separating license, Vitrea platform, Export+ add-ons, implementation, interfaces, support, and upgrades.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Canon CT VScore+ reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not publicly available - checked 2026-09-07 - Exact FDA submission

    The reviewed exact FDA packet and Canon product page do not establish current scoped security controls, certification scope, PHI flow, retention, access control, audit, or incident response.

  • Installation timeline: Not yet reviewed

8 sources - 3 history items

Source ledger

  1. FDA 510(k) K252217: CT VScore+

    U.S. Food and Drug Administration - Accessed 2026-09-07

    Scope: identity, clinicalUse, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, integration, deployment, evidenceMetrics, evidenceStudies

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. CT VScore+ model card (K252217)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. CT VScore+ in Canon Vitrea Advanced Visualization cardiac imaging

    Canon Medical Informatics - Accessed 2026-09-07

    Scope: productFamily, clinicalUse, implementationCapabilities, currentCommercialContext

  8. openFDA exact recall query for K252217

    U.S. Food and Drug Administration - Accessed 2026-09-07

    Scope: postmarketSafety

Research history

  1. K252217 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K251027

cvi42 Coronary Plaque Software Application

Circle Cardiovascular Imaging, Inc.

Authorized purpose: cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the presence and extent of coronary plaques and stenoses in CCTA for CAD or suspected CAD.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-10-27
FDA-cleared K251656

Careverse CoronaryDoc (Careverse CoronaryDoc)

Careverse Technology Pte. Ltd.

Authorized purpose: Careverse CoronaryDoc is a web-based tool for trained medical professionals to view and analyze CCTA CT data for coronary plaques and stenosis, with coronary measurements, visualization, automated plaque and stenosis outputs, and structured reporting for physician review.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-09-04
FDA-cleared K243859

PRAEVAorta®2

Nurea

Authorized purpose: PRAEVAorta 2 assists clinical specialists, physicians, and other licensed practitioners with automatic vascular segmentation and maximum-diameter measurement on adult CT images; results require clinical assessment and physician validation when obtained by a non-physician.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-08-29

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history